HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium Iodide → (R)-5-(2-(1H-pyrrol-1-yl)thiazol-4-yl)-2-morpholino-6-(piperidin-3-ylamino)pyrimidin-4(3H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Chlorotrimethylsilane | HCID 6397 | — |
| Reactant | (R)-tert-butyl 3-((5-(2-(1H-pyrrol-1-yl)thiazol-4-yl)-6-methoxy-2-morpholinopyrimidin-4-yl)amino)piperidine-1-carboxylate | HCID 117677378 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | (R)-5-(2-(1H-pyrrol-1-yl)thiazol-4-yl)-2-morpholino-6-(piperidin-3-ylamino)pyrimidin-4(3H)-one | HCID 136272323 | — |
Reaction Steps
To (R)-tert-butyl 3-((5-(2-(1H-pyrrol-1-yl)thiazol-4-yl)-6-methoxy-2-morpholinopyrimidin-4-yl)amino)piperidine-1-carboxylate (xx) (0.08 g, 0.148 mmol) in MeCN (2.95 ml) was added NaI (0.033 g, 0.222 mmol) followed by TMS-Cl (0.028 ml, 0.222 mmol) under argon. The reaction was stirred at room temperature for 15 min., then heated to 50° C. for 2 h until the reaction was complete, monitored by LCMS. The solvent was removed and the reaction material was purified by preparative HPLC to give the title compound. MS (m/z)=428 (M+H). IRAK4 IC50=12 nM
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09221809B2 |
| Source dataset | uspto-grants-2015_12 |
| ORD ID | ord-0f3513904d9349af90b1d52dcf51b6a3 |
| Source note | uspto-grants-2015_12 |